Global Preclinical CRO Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa. And It Is Incorporated On Marketresearchfuture.Com With 90 Pages.
Preclinical CRO Market – Synopsis
The Global Preclinical CRO Market held a market value of USD 4,450.2 million in 2017 and is projected to grow at a CAGR of 6.6% over the forecast period. Preclinical contract research organizations (CROs) are the service organizations that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services including bioanalysis & pharmacokinetics/pharmacodynamics (PK/PD) or drug metabolism and pharmacokinetics (DMPK), and toxicology testing.
The factors boosting the demand for preclinical CRO services are rising R&D budget for early- and late-stage drug development processes, a surge in the number of drug entities in preclinical phase and increasing focus of healthcare industries on their core competencies coupled with growth in outsourcing of noncore functions. The biopharmaceutical companies are emphasizing on their core functions in order to gain a long-term competitive advantage, thereby to bridge the gap between performance and opportunity. According to an article published in the BiopharmaTrend platform, biopharmaceutical companies are focusing on partnering with academia and CROs to outsource research activities to academic and private CROs as a strategy to stay competitive.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/7274
On the contrary, growth in the biologics & biosimilars market and accelerating demand for specialized testing services are anticipated to restrain the market growth during the forecast period.
Top Players:
Some of the major players in the global preclinical CRO market are PAREXEL International Corporation, IQVIA, Charles River, Envigo, Eurofins Scientific, ICON plc, PRA Health Sciences (PRA), Medpace, Laboratory Corporation of America Holdings, Pharmaceutical Product Development, LLC, WuXi AppTec, and MD Biosciences.
Segmentation
The global preclinical CRO market has been segmented into service, therapeutic area, and end user. The bioanalysis and DMPK studies segment are expected to exhibit profitable market growth due to rise in demand for pharmacokinetic services to support toxicology tests for investigational new drug (IND)-enabling studies.
By service, the market has been divided into bioanalysis and DMPK studies, toxicology testing, and others.
On the basis of therapeutic area, the market has been classified into oncology, diabetes, infectious diseases, immunological disorders, cardiovascular diseases, respiratory diseases, and others.
Based on end user, the market has been categorized into pharmaceutical & biopharmaceutical industries, medical device companies, and others.
Regional Analysis:
The global preclinical CRO market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is expected to dominate the global preclinical CRO market due to the presence of sophisticated healthcare infrastructure & the presence of early- stage drug development CROs, high-quality standards in the pharmaceutical industry, rising clinical trial activities, and rapid growth in its biosimilars & biologics market.
Rising partnerships, mergers & acquisitions among CRO service providers in European region is assisting in the regional market growth.
Preclinical CRO market in Asia-pacific to see significant growth prospect attributed to growing population, rising CRO outsourcing services in India and China due to cost-effectiveness and developing healthcare sector.
The Middle East & Africa has the least share of the global preclinical CRO market. Additionally, the major market share of the region would be held by the Middle East region due to improving quality healthcare in the Middle East. The healthcare sector is constantly changing in the Middle East, and the industry has seen many opportunities over the past few years. The speedily progressing technological landscape of the region would continue to shape healthcare in the near future.
Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/preclinical-cro-market-7274
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312